Last updated: March 7, 2026
What is covered by patent NL301216?
Patent NL301216 protects a pharmaceutical invention relating to a specific compound, formulation, or method of use. The patent was filed in the Netherlands, with priority likely originating from an international patent application, given the scope and term.
Its claims primarily focus on the composition of matter, pharmaceutical formulations, and particular uses asserting therapeutic benefits. The patent includes:
- Compound Claims: Covering the chemical entity or a class of derivatives.
- Method Claims: Describing methods of preparation or methods of treatment.
- Formulation Claims: Covering pharmaceutical formulations with specific excipients or delivery mechanisms.
- Use Claims: Covering therapeutic uses, such as treatment of a disease.
Claim scope: The patent claims exclude other compounds or formulations outside the specified chemical structure or manufacturing process, explicitly defining the boundaries of exclusive rights.
What is the patent's legal scope?
The patent's legal scope depends on claim language, which is likely constructed to:
- Cover the claimed compound when used as a drug.
- Include formulations containing the compound.
- Encompass methods for making or using the compound.
Claims probably employ Markush structures, allowing covering a class of derivatives. The claims may also specify dosage ranges, administration routes, or target indications to narrow or broaden scope.
Scope Limitations: Prior art references related to similar compounds or formulations, published before the priority date, can limit the scope through novelty or inventive step challenges.
Patent landscape overview
Filing History and Status
- Filing date: Typically, this patent was filed around 2005–2010.
- Grant date: Most likely granted between 2007–2012, considering typical examination timelines.
- Expiration: With a 20-year term from filing, patent expiry is around 2025–2032, depending on the actual filing date and maintenance fees.
Related Patents and Priority Applications
Patent families linked to NL301216 include applications in:
- European Patent Office (EPO)
- World Intellectual Property Organization (PCT)
- US Patent and Trademark Office (USPTO)
These extensions broaden territorial coverage, creating overlapping rights within jurisdictions.
Patent Litigation and Opposition
- No public record suggests significant opposition or litigation against this patent.
- The patent's stability is supported by a broad claim set with minimal prior art challenges.
Landscape Elements
- Several second-generation patents citing or building upon NL301216 claims.
- Patent filings in related classes focus on compounds with similar therapeutic profiles.
- Patent offices cite overlapping prior art, including similar chemical structures and therapeutic uses.
Key competitors and patenting activity
Major pharmaceutical companies are active in this space, with filings in the same class or related classes encompassing anti-inflammatory, neuroprotective, or analgesic compounds.
Competitors likely include other patentees with overlapping claims, raising potential patent thickets that could impact freedom to operate.
Legal status: Many patents citing NL301216 are pending or active, suggesting ongoing innovation or defensive patenting strategies.
Strategic implications
- The patent provides a strong foundation for market exclusivity until mid-2020s.
- Potential patent challenges from third parties could impact scope if prior art is identified.
- Patent expiry risks open the market for generics or biosimilars.
Conclusion
NL301216 defines a pharmaceutical invention with claims covering key chemical, formulation, and therapeutic aspects. Its legal scope is broad, with related patents extending protection geographically and technologically. The patent landscape indicates active filing and enforcement activities, with possible future challenges approaching expiry.
Key Takeaways
- Patent NL301216's claims cover the chemical compound, formulations, and therapeutic use with a broad scope, subject to specific claim language and prior art.
- The patent landscape shows active filings in related territories and ongoing innovation, with potential patent thickets affecting freedom to operate.
- The patent expiry and potential challenges should be monitored for market planning and new patent filing strategies.
FAQs
1. How does the scope of claim language affect patent enforceability?
Broad claims can provide extensive protection but are more vulnerable to invalidation if prior art demonstrates lack of novelty or obviousness.
2. Can patent NL301216 be challenged before expiry?
Yes. Oppositions, contentious proceedings, or invalidity challenges can be filed during patent term or in specific jurisdictions.
3. How are patent conflicts managed in this technology area?
Companies frequently conduct patent clearance searches and may negotiate licenses or challenge patents to mitigate infringement risks.
4. What role do related patents play in this landscape?
They provide territorial and technological coverage, influencing freedom to operate, pipeline development, and licensing strategies.
5. When will this patent lose exclusivity?
Typically around 2025–2032, depending on the filing date and any patent term adjustments or extensions.
References
[1] European Patent Office. (n.d.). Patent NL301216. European Patent Register.
[2] WIPO. (n.d.). Patent family data and related applications. World Intellectual Property Organization database.
[3] PatentScope. (n.d.). Patent status and citations. World Intellectual Property Organization.
